Symposium:
200. Infectious Diseases in the Americas: Bugs without Borders
Saturday, October 29, 2016: 8:30 AM-10:15 AM
Room: 393-396
Co-organized with Asociacion Panamericana de Infectologia

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • identify the major common infectious diseases threats in Latin America that may affect the US
  • describe the status and clinical features of Zika and Chikungunya infections in Latin America
  • discuss the epidemiology and clinical impact of KPC-producing Enterobacteriaceae in the Americas
  • distinguish the diverse clinical presentation of Trypanosoma cruzi in immunocompromised patient

Target Audience: Academicians, Clinicians, Fellows, Healthcare workers, Hospital epidemiologists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Members-in-training, Microbiologists, Nurses, Public health practitioners, Researchers, Scientists

Tracks: Global ID, Epidemiology and Infection Control, Investigative ID, Adult ID

Moderators:  Cesar Arias, MD, PhD, FIDSA, University of Texas McGovern Medical School at Houston and Wesley Van Voorhis, MD, PhD, FIDSA, University of Washington

CME Credits: Maximum of 1.75 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours 0.15 of pharmacy CE

ACPE Number: 0221-9999-16-282-L01-P

Disclosures:

C. Arias, Forest/Actavis: Grant Investigator and Speaker's Bureau , Research support
Theravance: Consultant , Grant Investigator and Speaker's Bureau , Grant recipient and Speaker honorarium
Pfizer: Grant Investigator , Scientific Advisor and Speaker's Bureau , Grant recipient and Speaker honorarium
Cubist: Consultant , Grant Investigator and Scientific Advisor , Consulting fee , Grant recipient and Speaker honorarium
Bayer: Consultant and Scientific Advisor , Consulting fee
Merck: Grant Investigator and Speaker's Bureau , Research grant and Speaker honorarium
Astra-Zeneca: Speaker's Bureau , Speaker honorarium
Novartis: Speaker's Bureau , Speaker honorarium
The Medicines Company: Speaker's Bureau , Speaker honorarium

W. Van Voorhis, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.